SARS-CoV2 RECEPTOR TARGETING FOR THE TREATMENT OF COVID 19 PATIENTS (CORONAVIRUS RECEPTOR TARGETING -“CORTAR”) Year: 2020 Financing entity: EUSKAMPUS. 2021
